Meds Apotek AB (STO:MEDS)
Sweden · Delayed Price · Currency is SEK 25.30
-0.30 (-1.17%)
At close: Sep 2, 2026
Meds Apotek AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 14.96 | 7.73 | -10.4 | -51.02 | - | - |
Depreciation & Amortization | 10.76 | 10.89 | 9.45 | 10.09 | - | - |
Other Amortization | 7.84 | 9.29 | 11.3 | 10.54 | - | - |
Other Operating Activities | -9.77 | -9.83 | -1.17 | -0.85 | - | - |
Change in Accounts Receivable | -1.58 | -7.19 | -13.98 | 1.27 | - | - |
Change in Inventory | -21.95 | -41.9 | -20.51 | -15.12 | - | - |
Change in Other Net Operating Assets | 13.29 | 9.77 | 45.59 | -4.52 | - | - |
Operating Cash Flow | 13.56 | -21.23 | 20.29 | -49.6 | - | - |
Operating Cash Flow Growth | -29.82% | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -5.33 | -0.6 | -0.45 | -0.18 | - | - |
Sale (Purchase) of Intangibles | -7.53 | -7.01 | -7.78 | -8.5 | - | - |
Investment in Securities | -0.4 | -0.37 | -0.3 | -0.13 | - | - |
Other Investing Activities | -0 | -0 | - | - | - | - |
Investing Cash Flow | -13.26 | -7.98 | -8.52 | -8.81 | - | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | 29.7 | - | - |
Long-Term Debt Repaid | - | -8.78 | -39.7 | -5.42 | - | - |
Net Debt Issued (Repaid) | -9.17 | -8.78 | -39.7 | 24.28 | - | - |
Issuance of Common Stock | 70 | 70 | - | 62.51 | - | - |
Other Financing Activities | -9.28 | -8.01 | -1.48 | -2.53 | - | - |
Financing Cash Flow | 51.55 | 53.21 | -41.18 | 84.26 | - | - |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | - | 0 | 0 | -0 | - | - |
Net Cash Flow | 51.85 | 24 | -29.42 | 25.85 | - | - |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 8.23 | -21.83 | 19.84 | -49.78 | - | - |
Free Cash Flow Growth | -55.74% | - | - | - | - | - |
Free Cash Flow Margin | 0.76% | -2.17% | 2.39% | -7.60% | - | - |
Free Cash Flow Per Share | 0.44 | -1.22 | 1.15 | -2.97 | - | - |
Levered Free Cash Flow | -2.07 | -28.45 | 12.9 | - | - | - |
Unlevered Free Cash Flow | -1.75 | -27.81 | 15.34 | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.52 | 1.03 | 3.91 | 3.81 | - | - |
Cash Income Tax Paid | 0.16 | -0.44 | 0.42 | 0.43 | - | - |
Change in Working Capital | -10.24 | -39.32 | 11.1 | -18.38 | - | - |